BioSig Technologies to Present at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society

BioSig Technologies (OTCQB:BSGM) announced its submission entitled “Enhanced Electrophysiology Recording System” was accepted as a Late Breaking Research Paper for presentation at the 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC2016).
As quoted in the press release:

The conference will be held at the Contemporary Resort in Orlando, Florida August 17 – 20, 2016. The overall theme of the conference is “Empowering Individual Healthcare Decisions through Technology” and will cover diverse topics from cutting-edge biomedical and healthcare technology research and development to clinical applications and biomedical education.
BioSig will have the opportunity to give an oral presentation during the “Ignite” session highlighting the key elements of the PURE EP System and results from the Company’s pre-clinical trials at Mayo Clinic with a poster session to follow.

BioSig Technologies VP of Clinical Research, Jay Millerhagen, stated:

We are honored to be approved by the scientific committee for the Late Breaking Research session at the prestigious EMBC 2016 conference and look forward to presenting a technical description of the PURE EP System along with pre-clinical results obtained at Mayo Clinic using our proprietary electrophysiology platform.

Connect with BioSig Technologies (OTCQB:BSGM) to receive an Investor Presentation.